Promising New Legislation Could Transform the FDA’s Drug Approval Process, Leading to Better Treatments and Lower Prices

Source: Foundation for Economic Education
by Al Musella & Bartley J Madden

“A radical departure from the standard drug-approval process enabled the development and distribution of life-saving vaccines that allow us to return to normal. But we should not forget that many Americans lost their lives due to the agency’s excessively slow and deliberate approach to approving COVID tests and new treatment options earlier last year. Despite the success of its COVID vaccine rollout, the FDA continues to plod along with time-consuming processes that delay access to life-enriching treatments to the many millions of patients battling cancer, heart disease, and countless other deadly and debilitating diseases.” (06/10/21)